Cellectis Announces the execution of the Subsequent Investment Agreement with AstraZeneca

Retrieved on: 2023-11-15 10:14:50

Tags for this article:

Click the tags to see associated articles and topics

Cellectis Announces the execution of the Subsequent Investment Agreement with AstraZeneca. View article details on hiswai:

Excerpt

Execution of binding subsequent investment agreement regarding contemplated additional equity investment of $140M by AstraZeneca, previously announced ...

Article found on: www.biospace.com

View Original Article